Hexagon Nutrition IPO Details
Hexagon Nutrition IPO Summary
Hexagon Nutrition IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.
Hexagon Nutrition IPO total issue size comprises 3,08,59,704 shares (aggregating up to ₹0.00 Cr.). This includes a fresh issue of 3,08,59,704 shares (aggregating up to ₹0.00 Cr.). Pre-issue shareholding stands at 11,06,27,404, which will increase to 11,06,27,404 post-issue.
Hexagon Nutrition IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.
Hexagon Nutrition IPO Details
Hexagon Nutrition IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| To be announced | |||
Hexagon Nutrition IPO Reservation
Promoter Holding
Documents
Hexagon Nutrition IPO Valuations
Hexagon Nutrition Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 261.36 | 250.54 | 288.90 |
| Total Income | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 24.38 | 12.21 | 5.82 |
| EBITDA | 40.07 | 24.88 | 17.17 |
| NET Worth | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 183.12 | 164.81 | 152.02 |
| Total Borrowing | 26.60 | 36.89 | 51.87 |
| Amount in ₹ Crore | |||
About Hexagon Nutrition IPO
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.
Its product portfolio is classified into three segments:
- Branded wellness and clinical nutrition products (B2C)
- Premix formulations (B2B2C)
- Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives
Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 342 distributors across India, including 8 with multi-state presence.
The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.
Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 11 qualified professionals. As of July 31, 2025, the company employed 482 people.
Strength Of Hexagon Nutrition IPO
Risk Of Hexagon Nutrition IPO
Objectives Hexagon Nutrition IPO
To be announced
Company Contact Details
Hexagon Nutrition Ltd.
404 Global Chamber
Adarsh Nagar Link Road
Andheri (W)
Mumbai, Maharashtra, 400053
Phone: +91 22 6213 6710
Email: cs.hnpl@hexagonnutrition.com
Website: https://hexagonnutrition.com/
Registrar Contact Details
Hexagon Nutrition FAQs
The Hexagon Nutrition IPO is a MAINBOARD public issue comprising 30859704 equity shares with a face value of ₹1 each, aggregating to a total issue size of ₹0.00 Cr.. The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.
The IPO opens for subscription on TBA, and closes on TBA.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at TBA.
Quick Links
Comments
